132533-03-0Relevant articles and documents
Bile acid-based 1,2,4-trioxanes: Synthesis and antimalarial assessment(1)
Singh, Chandan,Hassam, Mohammad,Verma, Ved Prakash,Singh, Ajit Shanker,Naikade, Niraj Krishna,Puri, Sunil K.,Maulik, Prakas R.,Kant, Ruchir
, p. 10662 - 10673 (2013/02/23)
A new series of bile acid-based trioxanes 23a-d, 24a-d, 25a-d, 26a, 26b, and 26d have been synthesized and assessed for their antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice by oral route. The antimalarial activity of these trioxanes showed a strong dependence on the side-chain length; shortening side-chain length lead to increase in activity. The antimalarial activity also showed even stronger dependence on the stereochemistry at C3 and C6 (C21 in Figure 5) of the trioxane moiety. Of the two diastereomers isolated of each of the trioxanes, more polar one was significantly more active than the less polar one. The more polar diastereomer of the trioxanes 26a, 26b, and 26d, were the most active compounds of the series. All these three trioxanes provided 100% protection at 24 mg/kg × 4 days. In this model β-arteether provided 100% and 20% protection at 48 mg/kg × 4 days and 24 mg/kg × 4 days, respectively.
SPIRO-1,2,4-TRIOXANES AS ANTIMALARIAL AGENTS
-
Page/Page column 13, (2010/11/28)
The present invention provides novel spiro trioxane series of general Formula (4). This invention also provides a process for the preparation of novel spiro trioxane series. These novel spiro-trioxane cmpounds useful as anti-malarial agents.
Orally active 1,2,4-trioxanes: Synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant Plasmodium yoelii nigeriensis in mice
Singh, Chandan,Malik, Heetika,Puri, Sunil K.
, p. 2794 - 2803 (2007/10/03)
Using easily accessible keto-trioxanes 7a-g as the starting materials, a series of new variously functionalized 1,2,4-trioxanes 10-36 have been prepared and evaluated for antimalarial activity against multi-drug-resistant Plasmodium yoelii nigeriensis in